West Nile - Innovator®+EWT
Manufacturer: Zoetis, Inc.
This treatment applies to Horses
Encephalomyelitis-west Nile Virus Vaccine
Eastern & Western, Killed Virus
Tetanus Toxoid
For vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, and tetanus. Efficacy of the West Nile fraction was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile virus. The vaccine protected 95% of the vaccinates against infection, while 82% of the controls were viremic.
Dosage and Administration:
Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.
Caution:
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
Remove Serial Number And Expiration Date Label And Place On The Animal's Medical Chart.
Pfizer Animal Health, Exton, PA 19341, USA
Div. Of Pfizer Inc, NY, NY 10017
U.S. Vet. License No. 189
Presentation:
10 mL: 10 Doses
Nac No.
36903440
PFIZER INC.
PFIZER ANIMAL HEALTH
235 E. 42ND ST., NEW YORK, NY, 10017
Telephone: 269-833-4000
Customer Service: 800-733-5500 and 800-793-0596
Veterinary Medical Investigations & Product Support: 800-366-5288
Technical Services (USA): 800-366-5288
This item is NON-RETURNABLE and NON-REFUNDABLE.